Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (åpner nytt vindu)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Kilde‎: Cancer 2013;119(21):3784-7.

Arkiv‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (åpner nytt vindu)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (åpner nytt vindu)

Chakrabarti S, Varma S, Singh S, Kumari S

Kilde‎: Eur J Haematol 1998;60(5):313-4.

Arkiv‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (åpner nytt vindu)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (åpner nytt vindu)

Delaney M, Matthews DC, Gernsheimer TB

Kilde‎: Pediatr Blood Cancer 2017;64(12):e26641.

Arkiv‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (åpner nytt vindu)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (åpner nytt vindu)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Kilde‎: J Urol 2010;184(3):1152-7.

Arkiv‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (åpner nytt vindu)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (åpner nytt vindu)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Kilde‎: Leuk Lymphoma 1995;19(1-2):141-4.

Arkiv‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (åpner nytt vindu)

Pediatric off-label use of recombinant factor VIIa. (åpner nytt vindu)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Kilde‎: Pediatrics 2009;123(3):1066-72.

Arkiv‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (åpner nytt vindu)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (åpner nytt vindu)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Kilde‎: Indian J Pediatr 2011;78(8):961-8.

Arkiv‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (åpner nytt vindu)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (åpner nytt vindu)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Kilde‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Arkiv‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (åpner nytt vindu)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (åpner nytt vindu)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Kilde‎: Pediatr Blood Cancer 2016;63(10):1822-8.

Arkiv‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (åpner nytt vindu)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (åpner nytt vindu)

Das P, Carcao M, Hitzler J

Kilde‎: Pediatr Blood Cancer 2006;47(2):206-9.

Arkiv‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (åpner nytt vindu)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (åpner nytt vindu)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Kilde‎: Pediatr Blood Cancer 2008;50(5):1013-7.

Arkiv‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (åpner nytt vindu)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (åpner nytt vindu)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Kilde‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

Arkiv‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (åpner nytt vindu)

Off-label use of recombinant factor VIIa in pediatric patients. (åpner nytt vindu)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Kilde‎: Pediatrics 2012;129(6):e1533-40.

Arkiv‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (åpner nytt vindu)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (åpner nytt vindu)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Kilde‎: Pediatr Blood Cancer 2013;60(7):1178-83.

Arkiv‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (åpner nytt vindu)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (åpner nytt vindu)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Kilde‎: Med Oncol 2010;27(1):16-9.

Arkiv‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (åpner nytt vindu)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (åpner nytt vindu)

Ucar C, Caliskan U

Kilde‎: Pediatr Hematol Oncol 2006;23(4):339-45.

Arkiv‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (åpner nytt vindu)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (åpner nytt vindu)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Kilde‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Arkiv‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (åpner nytt vindu)

The use of DDAVP in children with bleeding disorders. (åpner nytt vindu)

Ben-Ami T, Revel-Vilk S

Kilde‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

Arkiv‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (åpner nytt vindu)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (åpner nytt vindu)

Kobrinsky NL, Tulloch H

Kilde‎: J Pediatr 1988;112(6):993-6.

Arkiv‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (åpner nytt vindu)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (åpner nytt vindu)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Kilde‎: J Pediatr Surg 2013;48(3):689-94.

Arkiv‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (åpner nytt vindu)